close

Log in

Access to premium content is restricted to healthcare professionals / registered members. Login with your email address to continue.

Forgot Your Password?

Don't have an account? Sign up

This site is intended for Healthcare Professionals only

module menu icon

COPD: part two

COPD guidelines

GOLD report

NICE guidance

Non-pharmacological management

Extend your learning

module menu icon NICE guidance

You’re doing great.  (0% complete)

quiz close icon

module menu icon NICE guidance

In December 2018, the National Institute for Health and Care Excellence (NICE) published its update to the 2010 clinical guideline CG101 – Chronic obstructive pulmonary disease in over 16s: diagnosis and management. This was followed by a further update in July 2019, which focused on inhaled triple therapy for stable COPD and systemic corticosteroids for managing exacerbations. Triple therapy refers to the use of a long-acting beta2 agonist (LABA), long-acting antimuscarinic agent (LAMA) and ICS together, although not necessarily in one inhaler device.

These updates supplement the existing recommendations on:

  • Diagnosing COPD using symptoms, spirometry and other tests (see part one of this module)
  • Managing stable COPD using nebulisers, oral therapy and pulmonary rehabilitation
  • Multidisciplinary management of stable COPD, including physiotherapy, occupational therapy, nutrition and palliative care
  • Managing exacerbations of COPD in primary care and in hospital. NICE guidance should be used alongside the NICE quality standard for COPD care.

    • COPD: part two

    Continue Module
    Change privacy settings